The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFaron Pharma Share News (FARN)

Share Price Information for Faron Pharma (FARN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 150.00
Bid: 140.00
Ask: 160.00
Change: 0.00 (0.00%)
Spread: 20.00 (14.286%)
Open: 150.00
High: 150.00
Low: 150.00
Prev. Close: 150.00
FARN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK EXECUTIVE CHANGE SUMMARY: Corero Hires Former CML Finance Director

Mon, 27th Apr 2020 13:52

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Monday and not separately reported by Alliance News:

----------

Corero Network Security PLC - defence against denial of service cyber attacks - Hires Lionel Chmilewsky as chief executive officer designate, starting on Friday. Chmilewsky will take over as CEO from Ashley Stephenson on July 1. Stephenson will move over to chief technology officer, remaining on the board. Chmilewsky was most recently CEO of Cambridge Broadband Networks Ltd. Corero also hires Neil Pritchard as finance director, from Friday. Pritchard was financial director at CML Microsystems PLC. Andrew Miller steps down as chief financial officer of Corero but remains as a non-executive director. CML had announced Pritchard's departure back in November, saying at the time he had resigned "to pursue other career opportunities". It later said Non-Executive Chair Nigel Clark would take on the additional role of finance director while it reviews its finance function.

----------

Carclo PLC - engineering - Promotes Non-Executive Director Joe Oatley to chair, effective immediately. Oatley is the former CEO of industrial services firm Cape PLC. He joined Carclo board in July 2018 and also is on the board of construction company Wates Group Ltd. Carclo said that since Mark Rollins left as chair on March 24, the Covid-19 crisis has delayed the search for a permanent replacement, so Oatley agreed to be chair until a longer-term replacement is found. "The board believes that it is essential to have a chairman in place given the current challenging market environment and the need to secure a long-term financing position for the group," Carclo said.

----------

Aston Martin Lagonda Global Holdings PLC - car maker - Michael de Picciotto joins board immediately as representative non-executive director of Yew Tree Consortium. De Picciotto is vice chair of supervisory board of Engel & Volkers AG. He has waived his board fee for 2020. Yew Tree is a company controlled by lead investor and new Aston Martin chair Lawrence Stroll.

----------

ECO Animal Health Group PLC - livestock vaccines - Hires Frank Armstrong as non-executive director. Armstrong already is non-executive chair of Faron Pharmaceutical Oy and Caldan Therapeutics Ltd.

----------

Tristel PLC - infection prevention - Hires Isabel Napper as non-executive director. Napper was a partner at law firm Mills & Reeve and currently is a non-executive director of SDI Group PLC.

----------

Vaalco Energy Inc - exploration and development in West Africa - William Thomas resigns as president and from board with immediate effect. His "resignation was not in connection with any disagreement with the company on any matter relating to the company's operations, policies or practices," it notes.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
18 Mar 2021 16:06

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
12 Feb 2021 10:40

Faron Pharmaceuticals Raises EUR15 Million In Share Placing

Faron Pharmaceuticals Raises EUR15 Million In Share Placing

Read more
11 Feb 2021 17:49

IN BRIEF: Faron Pharmaceuticals Plans To Raise EUR15 Million

IN BRIEF: Faron Pharmaceuticals Plans To Raise EUR15 Million

Read more
26 Jan 2021 11:45

IN BRIEF: Faron Pharmaceuticals Gets US Approval For Covid-19 Trial

IN BRIEF: Faron Pharmaceuticals Gets US Approval For Covid-19 Trial

Read more
20 Jan 2021 15:12

Faron Notes "Remarkable" Observations From Bexmarilimab Trial

Faron Notes "Remarkable" Observations From Bexmarilimab Trial

Read more
20 Jan 2021 10:40

LONDON AIM WINNERS & LOSERS: Sabien Sinks On Ptarmigan Deal Withdrawal

LONDON AIM WINNERS & LOSERS: Sabien Sinks On Ptarmigan Deal Withdrawal

Read more
18 Jan 2021 10:41

LONDON AIM WINNERS & LOSERS: CPPGroup Earnings To Beat Forecasts

LONDON AIM WINNERS & LOSERS: CPPGroup Earnings To Beat Forecasts

Read more
18 Jan 2021 10:22

Faron Pharmaceuticals Gets USD6 Million Funding For Covid-19 Treatment

Faron Pharmaceuticals Gets USD6 Million Funding For Covid-19 Treatment

Read more
23 Nov 2020 21:12

IN BRIEF: Four Cohorts In Faron Pharmaceuticals Study Move To Part 3

IN BRIEF: Four Cohorts In Faron Pharmaceuticals Study Move To Part 3

Read more
24 Sep 2020 14:02

IN BRIEF: Faron Pharmaceuticals Says Virus Barely Affected Operations

IN BRIEF: Faron Pharmaceuticals Says Virus Barely Affected Operations

Read more
17 Sep 2020 16:03

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
18 Aug 2020 11:55

Faron Gets EUR2.5 Million Loan Guarantee For Traumakine Production

Faron Gets EUR2.5 Million Loan Guarantee For Traumakine Production

Read more
15 Jun 2020 13:05

IN BRIEF: Faron Pharma Receives EUR2.1 Million Loan To Develop Product

IN BRIEF: Faron Pharma Receives EUR2.1 Million Loan To Develop Product

Read more
15 Jun 2020 12:44

Faron Pharmaceuticals gets Finnish state loan for manufacturing process

(Sharecast News) - Clinical-stage biopharmaceutical company Faron Pharmaceuticals announced plans to initiate a new "state-of-the-art" process for the manufacturing of 'interferon' (IFN) beta-1a on Monday.

Read more
11 Jun 2020 13:51

Faron receives EIC grant for 'MATINS' study

(Sharecast News) - Clinical-stage biopharmaceuticals company Faron Pharmaceuticals has been selected to receive a €2.5m (£2.24m) grant from the European Innovation Council's 'Accelerator' pilot scheme, it announced on Thursday, to progress the 'MATINS' study, and related business activities.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.